2026/0126 - Convite à apresentação de proposta por ajuste direto para aquisição de AMIVANTAMAB [50 MG/ML; 7 ML; SOL INJ; FRS], BOSENTANO [32 MG; COMP DISP], BEDAQUILINA [100 MG; CÁP/COMP], DARUNAVIR [100 MG/ML; SUSP ORAL; FRS], TECLISTAMAB [90 MG/ML; 1,7 ML; SOL INJ; FRS] e TECLISTAMAB [10 MG/ML; 3 ML; SOL INJ; FRS]

ID 13634306 · Portal BASE
Price
Base Price
€1,602,358 .00
Effective Price
€4,705 .00 -99.7%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Amadora
Bidder Count
—
Winner
JANSSEN - CILAG FARMACÊUTICA LDA
NIF 500189412
Company
Dates
Publication
25 Feb 2026
Celebration
25 Feb 2026
Contracting Entity
HOSPITAL PROFESSOR DOUTOR FERNANDO FONSECA, EPE
NIF 503035416
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
1602358.0
Total effective price
4705.0
Ratio
0.0029
Direction
reduction
Rule
A9 price reduction: ratio 0.0029 outside [0.5, 1.5]
Detected 2026-03-06